Authorities in south China apologize over COVID-19 break-ins
Authorities in southern China are apologizing for breaking into the homes of people quarantined for being suspected of contracting COVID-19
Authorities in south China apologize over COVID-19 break-ins
Show all 6Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Authorities in southern China apologized for breaking into the homes of people quarantined for being suspected of contracting COVID-19 in the latest example of heavy-handed measures that have sparked a rare public backlash.
The Communist Party newspaper Global Times reported Tuesday that 84 homes of people sent for isolation in Guangzhou city’s Liwan district were opened in an effort to find close contacts remaining inside and to disinfect the premises.
The doors were later sealed and new locks installed, the paper reported.
The district government apologized for such “oversimplified and violent” behavior, the paper said. An investigation team has been set up to investigate and “relevant people" will be severely punished, it said.
China's leadership has maintained its hard-line “zero-COVID” policy despite the mounting economic costs and disruption to the lives of ordinary citizens, who continue to be subjected to routine testing and quarantines, even while the rest of the world has opened up to living with the disease.
Numerous cases of police and health workers breaking into homes around China in the name of anti-COVID-19 measures have been documented on social media. In some, doors have been broken down and residents threatened with punishment, even when they tested negative for the virus. Authorities have demanded keys to lock in residents of apartment buildings where cases have been detected, steel barriers erected to prevent them leaving their compounds and iron bars welded over doors.
China's Communist leaders exert stringent control over the government, police and levers of social control. Most citizens are inured to a lack of privacy and restrictions on free speech and the right to assembly.
However, the strict anti-COVID-19 measures have tested that tolerance, particularly in Shanghai, where a ruthless and often chaotic lockdown spurred protests online and in person among those unable to access food, health care and basic necessities.
Authorities in Beijing have taken a gentler approach, concerned with prompting unrest in the capital ahead of a key party congress later this year at which president and party leader Xi Jinping is expected to receive a third five-year term amid radically slower economic growth and high unemployment among college graduates and migrant workers. A requirement that only vaccinated people could enter public spaces was swiftly canceled last week after city residents denounced it as having been announced without warning and unfair to those who have not had their shots.
“Zero-COVID” has been justified as necessary to avoid a wider outbreak among a population that has had relatively little exposure to the virus and less natural immunity. Although China's vaccination rate hovers at around 90%, it is considerably lower among the elderly, while questions have been raised about the efficacy of China's domestically produced vaccines.
Although China's Fosun Pharma reached an agreement to distribute, and eventually manufacture, the mRNA vaccine made by Pfizer and BioNTech, it still has not been cleared for use in mainland China, despite being authorized for use by separate authorities in Hong Kong and Macao.
Studies have consistently shown that inoculation with mRNA vaccines offers the best protection against hospitalization and death from COVID-19. Chinese vaccines made with older technology proved fairly effective against the original strain of the virus, but much less so against more recent variants.
Now health experts say the delay in approving mRNA vaccines — a consequence of placing politics and national pride above public health — could lead to avoidable coronavirus deaths and deeper economic losses.
China's national borders remain largely closed and although domestic tourism has picked up, travel around the country remains subject to an array of regulations, with quarantine restrictions constantly in flux.
In one recent incident, some 2,000 visitors to the southern tourist hub of Beihai have been forced to prolong their stays after more than 500 cases were found and they were barred from leaving.
The local government was struggling to find hotel rooms for those who had already prepared to return home, while hotels and airlines were providing refunds for those who had booked holidays to the city that had to be canceled.
China regulates travel and access to public places through a health code app on citizens' smartphones that must be updated with regular testing. The app tracks a person's movements as a form of contact tracing, allowing a further imposition of public monitoring.
The measures remain in place despite relatively low rates of infection. The National Health Commission on Tuesday announced just 699 new cases of domestic transmission detected over the previous 24 hours, the bulk of which were asymptomatic.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.